Literature DB >> 2548327

Rescue of Sendai virus from viral ribonucleoprotein-transfected cells by infection with recombinant vaccinia viruses carrying Sendai virus L and P/C genes.

H Gotoh1, T Shioda, Y Sakai, K Mizumoto, H Shibuta.   

Abstract

The Sendai virus ribonucleoprotein (RNP) showed only very low plaque-forming titers upon transfection and the virus yields after one-step growth were quite limited. We tried to enhance the Sendai virus yield by supplying the viral L and P/C gene products through vaccinia vectors. A combination of the recombinant vaccinia viruses carrying the L gene (Vac-HL) and the P/C gene (Vac-HPC), both of which were driven by the promoter of the vaccinia virus 7.5K protein gene, enhanced the yield only a little whereas another combination of Vac-HLd7.5, the L gene insert of which was driven by the promoter of the vaccinia virus thymidine kinase gene in place of the 7.5K promoter, and Vac-HPC greatly enhanced the Sendai virus yield. This seemed to correlate with the fact that the Vac-HL interfered with Sendai virus growth markedly while the Vac-HLd7.5 did not. These results strongly suggest that the L and P/C gene products act in cooperation as the RNA polymerase, and overproduction of the L protein is inhibitory for Sendai virus growth. This system seems to be of value as a tool for analyzing the functions of L and P/C genes of Sendai virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548327     DOI: 10.1016/0042-6822(89)90612-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols.

Authors:  T Yoshida; K Okuda; K Q Xin; K Tadokoro; J Fukushima; S Toda; E Hagiwara; K Hamajima; T Koshino; T Saito
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

2.  Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro.

Authors:  S M Horikami; J Curran; D Kolakofsky; S A Moyer
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Determination of influenza virus proteins required for genome replication.

Authors:  T S Huang; P Palese; M Krystal
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

4.  Expression of functional Bunyamwera virus L protein by recombinant vaccinia viruses.

Authors:  H Jin; R M Elliott
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Studies on the regulation of influenza virus RNA replication: a differential inhibition of the synthesis of vRNA segments in shift-up experiments with ts mutants.

Authors:  L V Gubareva; N L Varich; S G Markushin; N V Kaverin
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein.

Authors:  H E Homann; W Willenbrink; C J Buchholz; W J Neubert
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Assembly of functional Sindbis virus RNA replication complexes: requirement for coexpression of P123 and P34.

Authors:  J A Lemm; C M Rice
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation.

Authors:  J Curran; H Homann; C Buchholz; S Rochat; W Neubert; D Kolakofsky
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Mapping of a region of the paramyxovirus L protein required for the formation of a stable complex with the viral phosphoprotein P.

Authors:  G D Parks
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Long-term replication of Sendai virus defective interfering particle nucleocapsids in stable helper cell lines.

Authors:  W Willenbrink; W J Neubert
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.